Revisiting Minimally Invasive Distal Pancreatectomy
Mené sur 258 patients atteints d’un cancer du pancréas résécable d’emblée (durée médiane de suivi : 38 mois), cet essai randomisé international compare l'efficacité, du point de vue de la survie globale et de la survie sans maladie, de 2 types de pancréatectomie gauche, l'une mini-invasive et l'autre par voie ouverte
Minimally invasive surgical approaches have transformed many surgical domains, yet concerns about oncologic adequacy and technical complexity persist. The DIPLOMA trial addressed these concerns by evaluating whether minimally invasive left pancreatectomy (MILP) is oncologically noninferior to open left pancreatectomy (OLP), focusing on R0 resection rates. Earlier trials, including LEOPARD and LAPOP, demonstrated improved perioperative outcomes with MILP compared with OLP, and DIPLOMA’s initial findings confirmed comparable short-term oncologic outcomes, establishing an important benchmark for minimally invasive pancreatic surgery.
JAMA Surgery , éditorial, 2025